Inhibition of peroxisome-proliferator-activated receptor (PPAR)α by MK886

J. P. Kehrer, S. S. Biswal, E. La, Philippe Thuillier, K. Datta, S. M. Fischer, J. P. Vanden Heuvel

Research output: Contribution to journalArticle

132 Citations (Scopus)

Abstract

Although MK886 was originally identified as an inhibitor of 5-lipoxygenase activating protein (FLAP), recent data demonstrate that this activity does not underlie its ability to induce apoptosis [Datta, Biswal and Kehrer (1999) Biochem. J. 340, 371-375]. Since FLAP is a fatty-acid binding protein, it is conceivable that MK886 may affect other such proteins. A family of nuclear receptors that are activated by fatty acids and their metabolites, the peroxisome-proliferator-activated receptors (PPARs), have been implicated in apoptosis and may represent a target for MK886. The ability of MK886 to inhibit PPAR-α, -β and -γ activity was assessed using reporter assay systems (peroxisome-proliferator response element-luciferase). Using a transient transfection system in monkey kidney fibroblast CV-1 cells, mouse keratinocyte 308 cells and human lung adenocarcinoma A549 cells, 10-20 μM MK886 inhibited Wy 14,643 activation of PPARα by approximately 80%. Similar inhibition of PPARα by MK886 was observed with a stable transfection reporter system in CV-1 cells. Only minimal inhibitory effects were seen on PPARβ and PPARγ. MK886 inhibited PPARα by a non-competitive mechanism as shown by its effects on the binding of arachidonic acid to PPARα protein, and a dose-response study using a transient transfection reporter assay in COS-1 cells. An assay assessing PPAR ligand-receptor interactions showed that MK886 prevents the conformational change necessary for active-complex formation. The expression of keratin-1, a protein encoded by a PPARα-responsive gene, was reduced by MK886 in a culture of mouse primary keratinocytes, suggesting that PPAR inhibition has functional consequences in normal cells. Although Jurkat cells express all PPAR isoforms, various PPARα and PPARγ agonists were unable to prevent MK886-induced apoptosis. This is consistent with MK886 functioning as a non-competitive inhibitor of PPARα, but may also indicate that PPARα is not directly involved in MK886-induced apoptosis. Although numerous PPAR activators have been identified, the results show that MK886 can inhibit PPARα, making it the first compound identified to have such an effect.

Original languageEnglish (US)
Pages (from-to)899-906
Number of pages8
JournalBiochemical Journal
Volume356
Issue number3
DOIs
StatePublished - Jun 15 2001
Externally publishedYes

Fingerprint

Peroxisome Proliferator-Activated Receptors
Apoptosis
Transfection
Assays
Keratinocytes
5-Lipoxygenase-Activating Protein Inhibitors
Keratin-1
Peroxisome Proliferators
Fatty Acid-Binding Proteins
Proteins
Jurkat Cells
COS Cells

Keywords

  • 5-Lipoxygenase
  • Activating protein
  • Apoptosis
  • Cell signalling

ASJC Scopus subject areas

  • Biochemistry

Cite this

Kehrer, J. P., Biswal, S. S., La, E., Thuillier, P., Datta, K., Fischer, S. M., & Vanden Heuvel, J. P. (2001). Inhibition of peroxisome-proliferator-activated receptor (PPAR)α by MK886. Biochemical Journal, 356(3), 899-906. https://doi.org/10.1042/0264-6021:3560899

Inhibition of peroxisome-proliferator-activated receptor (PPAR)α by MK886. / Kehrer, J. P.; Biswal, S. S.; La, E.; Thuillier, Philippe; Datta, K.; Fischer, S. M.; Vanden Heuvel, J. P.

In: Biochemical Journal, Vol. 356, No. 3, 15.06.2001, p. 899-906.

Research output: Contribution to journalArticle

Kehrer, JP, Biswal, SS, La, E, Thuillier, P, Datta, K, Fischer, SM & Vanden Heuvel, JP 2001, 'Inhibition of peroxisome-proliferator-activated receptor (PPAR)α by MK886', Biochemical Journal, vol. 356, no. 3, pp. 899-906. https://doi.org/10.1042/0264-6021:3560899
Kehrer, J. P. ; Biswal, S. S. ; La, E. ; Thuillier, Philippe ; Datta, K. ; Fischer, S. M. ; Vanden Heuvel, J. P. / Inhibition of peroxisome-proliferator-activated receptor (PPAR)α by MK886. In: Biochemical Journal. 2001 ; Vol. 356, No. 3. pp. 899-906.
@article{9e732fff570e4617bef8d89ca8a3833d,
title = "Inhibition of peroxisome-proliferator-activated receptor (PPAR)α by MK886",
abstract = "Although MK886 was originally identified as an inhibitor of 5-lipoxygenase activating protein (FLAP), recent data demonstrate that this activity does not underlie its ability to induce apoptosis [Datta, Biswal and Kehrer (1999) Biochem. J. 340, 371-375]. Since FLAP is a fatty-acid binding protein, it is conceivable that MK886 may affect other such proteins. A family of nuclear receptors that are activated by fatty acids and their metabolites, the peroxisome-proliferator-activated receptors (PPARs), have been implicated in apoptosis and may represent a target for MK886. The ability of MK886 to inhibit PPAR-α, -β and -γ activity was assessed using reporter assay systems (peroxisome-proliferator response element-luciferase). Using a transient transfection system in monkey kidney fibroblast CV-1 cells, mouse keratinocyte 308 cells and human lung adenocarcinoma A549 cells, 10-20 μM MK886 inhibited Wy 14,643 activation of PPARα by approximately 80{\%}. Similar inhibition of PPARα by MK886 was observed with a stable transfection reporter system in CV-1 cells. Only minimal inhibitory effects were seen on PPARβ and PPARγ. MK886 inhibited PPARα by a non-competitive mechanism as shown by its effects on the binding of arachidonic acid to PPARα protein, and a dose-response study using a transient transfection reporter assay in COS-1 cells. An assay assessing PPAR ligand-receptor interactions showed that MK886 prevents the conformational change necessary for active-complex formation. The expression of keratin-1, a protein encoded by a PPARα-responsive gene, was reduced by MK886 in a culture of mouse primary keratinocytes, suggesting that PPAR inhibition has functional consequences in normal cells. Although Jurkat cells express all PPAR isoforms, various PPARα and PPARγ agonists were unable to prevent MK886-induced apoptosis. This is consistent with MK886 functioning as a non-competitive inhibitor of PPARα, but may also indicate that PPARα is not directly involved in MK886-induced apoptosis. Although numerous PPAR activators have been identified, the results show that MK886 can inhibit PPARα, making it the first compound identified to have such an effect.",
keywords = "5-Lipoxygenase, Activating protein, Apoptosis, Cell signalling",
author = "Kehrer, {J. P.} and Biswal, {S. S.} and E. La and Philippe Thuillier and K. Datta and Fischer, {S. M.} and {Vanden Heuvel}, {J. P.}",
year = "2001",
month = "6",
day = "15",
doi = "10.1042/0264-6021:3560899",
language = "English (US)",
volume = "356",
pages = "899--906",
journal = "Biochemical Journal",
issn = "0264-6021",
publisher = "Portland Press Ltd.",
number = "3",

}

TY - JOUR

T1 - Inhibition of peroxisome-proliferator-activated receptor (PPAR)α by MK886

AU - Kehrer, J. P.

AU - Biswal, S. S.

AU - La, E.

AU - Thuillier, Philippe

AU - Datta, K.

AU - Fischer, S. M.

AU - Vanden Heuvel, J. P.

PY - 2001/6/15

Y1 - 2001/6/15

N2 - Although MK886 was originally identified as an inhibitor of 5-lipoxygenase activating protein (FLAP), recent data demonstrate that this activity does not underlie its ability to induce apoptosis [Datta, Biswal and Kehrer (1999) Biochem. J. 340, 371-375]. Since FLAP is a fatty-acid binding protein, it is conceivable that MK886 may affect other such proteins. A family of nuclear receptors that are activated by fatty acids and their metabolites, the peroxisome-proliferator-activated receptors (PPARs), have been implicated in apoptosis and may represent a target for MK886. The ability of MK886 to inhibit PPAR-α, -β and -γ activity was assessed using reporter assay systems (peroxisome-proliferator response element-luciferase). Using a transient transfection system in monkey kidney fibroblast CV-1 cells, mouse keratinocyte 308 cells and human lung adenocarcinoma A549 cells, 10-20 μM MK886 inhibited Wy 14,643 activation of PPARα by approximately 80%. Similar inhibition of PPARα by MK886 was observed with a stable transfection reporter system in CV-1 cells. Only minimal inhibitory effects were seen on PPARβ and PPARγ. MK886 inhibited PPARα by a non-competitive mechanism as shown by its effects on the binding of arachidonic acid to PPARα protein, and a dose-response study using a transient transfection reporter assay in COS-1 cells. An assay assessing PPAR ligand-receptor interactions showed that MK886 prevents the conformational change necessary for active-complex formation. The expression of keratin-1, a protein encoded by a PPARα-responsive gene, was reduced by MK886 in a culture of mouse primary keratinocytes, suggesting that PPAR inhibition has functional consequences in normal cells. Although Jurkat cells express all PPAR isoforms, various PPARα and PPARγ agonists were unable to prevent MK886-induced apoptosis. This is consistent with MK886 functioning as a non-competitive inhibitor of PPARα, but may also indicate that PPARα is not directly involved in MK886-induced apoptosis. Although numerous PPAR activators have been identified, the results show that MK886 can inhibit PPARα, making it the first compound identified to have such an effect.

AB - Although MK886 was originally identified as an inhibitor of 5-lipoxygenase activating protein (FLAP), recent data demonstrate that this activity does not underlie its ability to induce apoptosis [Datta, Biswal and Kehrer (1999) Biochem. J. 340, 371-375]. Since FLAP is a fatty-acid binding protein, it is conceivable that MK886 may affect other such proteins. A family of nuclear receptors that are activated by fatty acids and their metabolites, the peroxisome-proliferator-activated receptors (PPARs), have been implicated in apoptosis and may represent a target for MK886. The ability of MK886 to inhibit PPAR-α, -β and -γ activity was assessed using reporter assay systems (peroxisome-proliferator response element-luciferase). Using a transient transfection system in monkey kidney fibroblast CV-1 cells, mouse keratinocyte 308 cells and human lung adenocarcinoma A549 cells, 10-20 μM MK886 inhibited Wy 14,643 activation of PPARα by approximately 80%. Similar inhibition of PPARα by MK886 was observed with a stable transfection reporter system in CV-1 cells. Only minimal inhibitory effects were seen on PPARβ and PPARγ. MK886 inhibited PPARα by a non-competitive mechanism as shown by its effects on the binding of arachidonic acid to PPARα protein, and a dose-response study using a transient transfection reporter assay in COS-1 cells. An assay assessing PPAR ligand-receptor interactions showed that MK886 prevents the conformational change necessary for active-complex formation. The expression of keratin-1, a protein encoded by a PPARα-responsive gene, was reduced by MK886 in a culture of mouse primary keratinocytes, suggesting that PPAR inhibition has functional consequences in normal cells. Although Jurkat cells express all PPAR isoforms, various PPARα and PPARγ agonists were unable to prevent MK886-induced apoptosis. This is consistent with MK886 functioning as a non-competitive inhibitor of PPARα, but may also indicate that PPARα is not directly involved in MK886-induced apoptosis. Although numerous PPAR activators have been identified, the results show that MK886 can inhibit PPARα, making it the first compound identified to have such an effect.

KW - 5-Lipoxygenase

KW - Activating protein

KW - Apoptosis

KW - Cell signalling

UR - http://www.scopus.com/inward/record.url?scp=0035875376&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035875376&partnerID=8YFLogxK

U2 - 10.1042/0264-6021:3560899

DO - 10.1042/0264-6021:3560899

M3 - Article

C2 - 11389700

AN - SCOPUS:0035875376

VL - 356

SP - 899

EP - 906

JO - Biochemical Journal

JF - Biochemical Journal

SN - 0264-6021

IS - 3

ER -